{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:11:07Z","timestamp":1793769067839,"version":"4.6.1"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN2018\/602"],"award-info":[{"award-number":["CAN2018\/602"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.biopha.2023.114644","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T17:12:37Z","timestamp":1680541957000},"page":"114644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Review on the effect of chemotherapy on the intestinal barrier: Epithelial permeability, mucus and bacterial translocation"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5586-2906","authenticated-orcid":false,"given":"David","family":"Dahlgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Lennern\u00e4s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114644_bib1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.stem.2010.11.016","article-title":"Tissue-resident adult stem cell populations of rapidly self-renewing organs","volume":"7","author":"Barker","year":"2010","journal-title":"Cell stem Cell"},{"key":"10.1016\/j.biopha.2023.114644_bib2","doi-asserted-by":"crossref","unstructured":"Keefe, D.M.; Gibson, R.J.; Hauer-Jensen, M. Gastrointestinal mucositis. In Proceedings of the Seminars in oncology nursing, 2004; pp. 38\u201347.","DOI":"10.1053\/j.soncn.2003.10.007"},{"key":"10.1016\/j.biopha.2023.114644_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/CCO.0000000000000180","article-title":"Mucositis: pathobiology and management","volume":"27","author":"Villa","year":"2015","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.biopha.2023.114644_bib4","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/cncr.32802","article-title":"Annual report to the nation on the status of cancer, part I: national cancer statistics","volume":"126","author":"Henley","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2023.114644_bib5","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/cncr.20163","article-title":"Clinical practice guidelines for the prevention and treatment of cancer therapy\u2013induced oral and gastrointestinal mucositis","volume":"100","author":"Rubenstein","year":"2004","journal-title":"Cancer: Interdiscip. Int. J. Am. Cancer Soc."},{"key":"10.1016\/j.biopha.2023.114644_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrgastro.2016.169","article-title":"The intestinal epithelial barrier: a therapeutic target?","volume":"14","author":"Odenwald","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2023.114644_bib7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","article-title":"Immunological effects of conventional chemotherapy and targeted anticancer agents","volume":"28","author":"Galluzzi","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2023.114644_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nri2216","article-title":"Immunological aspects of cancer chemotherapy","volume":"8","author":"Zitvogel","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2023.114644_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms4641","article-title":"Sophisticated digestive systems in early arthropods","volume":"5","author":"Vannier","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.114644_bib10","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/jps.24258","article-title":"Direct In vivo human intestinal permeability (Peff) determined with different clinical perfusion and intubation methods","volume":"104","author":"Dahlgren","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.114644_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002533","article-title":"Revised estimates for the number of human and bacteria cells in the body","volume":"14","author":"Sender","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.biopha.2023.114644_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0168-1605(98)00044-0","article-title":"Overview of gut flora and probiotics","volume":"41","author":"Holzapfel","year":"1998","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.biopha.2023.114644_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41385-019-0227-4","article-title":"IgA and the intestinal microbiota: the importance of being specific","volume":"13","author":"Pabst","year":"2020","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biopha.2023.114644_bib14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fimmu.2020.00646","article-title":"An update review on the Paneth cell as key to ileal Crohn's disease","volume":"11","author":"Wehkamp","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.114644_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nri2335","article-title":"Dendritic cells in intestinal immune regulation","volume":"8","author":"Coombes","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2023.114644_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41575-018-0081-y","article-title":"Tales from the crypt: new insights into intestinal stem cells","volume":"16","author":"Gehart","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2023.114644_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jb\/mvv121","article-title":"Intestinal M cells","volume":"159","author":"Ohno","year":"2016","journal-title":"J. Biochem."},{"key":"10.1016\/j.biopha.2023.114644_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-physiol-021115-105439","article-title":"Enteroendocrine cells: chemosensors in the intestinal epithelium","volume":"78","author":"Gribble","year":"2016","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.biopha.2023.114644_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1152\/physiol.00027.2004","article-title":"The molecular physiology of tight junction pores","volume":"19","author":"Van Itallie","year":"2004","journal-title":"Physiology"},{"key":"10.1016\/j.biopha.2023.114644_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-201x.1999.00510.x","article-title":"Jejunal permeability in humans in vivo and rats in situ: investigation of molecular size selectivity and solvent drag","volume":"165","author":"Fagerholm","year":"1999","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.biopha.2023.114644_bib21","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.clnu.2015.01.012","article-title":"The role of immunomodulators on intestinal barrier homeostasis in experimental models","volume":"34","author":"Andrade","year":"2015","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.biopha.2023.114644_bib22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrgastro.2013.35","article-title":"The gastrointestinal mucus system in health and disease","volume":"10","author":"Johansson","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2023.114644_bib23","series-title":"In Comprehensive Pharmacology","first-page":"30","article-title":"Oral drug delivery, absorption and bioavailability","author":"Dahlgren","year":"2021"},{"key":"10.1016\/j.biopha.2023.114644_bib24","first-page":"361","article-title":"Investigations into the diffusion behaviour of polypeptides in native intestinal mucus with regard to their peroral administration","volume":"2","author":"Bernkop\u2010Schn\u00fcrch","year":"1996","journal-title":"Pharm. Pharmacol. Commun."},{"key":"10.1016\/j.biopha.2023.114644_bib25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nri.2016.88","article-title":"Immunological aspects of intestinal mucus and mucins","volume":"16","author":"Johansson","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2023.114644_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrmicro3552","article-title":"Gut biogeography of the bacterial microbiota","volume":"14","author":"Donaldson","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2023.114644_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnbeh.2018.00104","article-title":"From the bottom-up: chemotherapy and gut-brain axis dysregulation","volume":"12","author":"Bajic","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.biopha.2023.114644_bib28","first-page":"2075","article-title":"Emerging evidence on the pathobiology of mucositis","volume":"21","author":"Al-Dasooqi","year":"2013","journal-title":"Support. care Cancer"},{"key":"10.1016\/j.biopha.2023.114644_bib29","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.oraloncology.2009.08.006","article-title":"Mucositis: the impact, biology and therapeutic opportunities of oral mucositis","volume":"45","author":"Sonis","year":"2009","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.biopha.2023.114644_bib30","first-page":"4023","article-title":"The pathogenesis of mucositis: updated perspectives and emerging targets","volume":"27","author":"Bowen","year":"2019","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.biopha.2023.114644_bib31","first-page":"713","article-title":"Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage","volume":"14","author":"Bowen","year":"2006","journal-title":"Support. care Cancer"},{"key":"10.1016\/j.biopha.2023.114644_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110675","article-title":"The role of Wnt\/\u03b2-catenin signaling in enterocyte turnover during methotrexate-induced intestinal mucositis in a rat","volume":"9","author":"Sukhotnik","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2023.114644_bib33","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3389\/fphar.2021.681417","article-title":"Chemotherapeutics-induced intestinal mucositis: pathophysiology and potential treatment strategies","volume":"12","author":"Dahlgren","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114644_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105296","article-title":"Direct costs associated with the management of mucositis: a systematic review","volume":"118","author":"Rodrigues-Oliveira","year":"2021","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.biopha.2023.114644_bib35","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s10620-019-05777-2","article-title":"The \u201cleaky gut\u201d: tight junctions but loose associations?","volume":"65","author":"Hollander","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2023.114644_bib36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00134-011-2172-x","article-title":"Acute intestinal failure in critically ill patients: is plasma citrulline the right marker?","volume":"37","author":"Piton","year":"2011","journal-title":"Intensive care Med."},{"key":"10.1016\/j.biopha.2023.114644_bib37","first-page":"416","article-title":"State of the art: the role of citrulline as biomarker in patients with chemotherapy-or graft-versus-host-disease-induced mucositis","volume":"24","author":"Dekker","year":"2021","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.biopha.2023.114644_bib38","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","article-title":"Leaky gut: mechanisms, measurement and clinical implications in humans","volume":"68","author":"Camilleri","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2023.114644_bib39","first-page":"1","article-title":"Surface area of the digestive tract-revisited","author":"Helander","year":"2014","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2023.114644_bib40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02209146","article-title":"Physiological regulation of transepithelial impedance in the intestinal mucosa of rats and hamsters","volume":"100","author":"Pappenheimer","year":"1987","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.biopha.2023.114644_bib41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02209145","article-title":"Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat","volume":"100","author":"Pappenheimer","year":"1987","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.biopha.2023.114644_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1159\/000233282","article-title":"Mechanisms and functional implications of intestinal barrier defects","volume":"27","author":"Shen","year":"2009","journal-title":"Dig. Dis."},{"key":"10.1016\/j.biopha.2023.114644_bib43","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1053\/gast.2000.18148","article-title":"Permeability of the rat small intestinal epithelium along the villus-crypt axis: effects of glucose transport","volume":"119","author":"Fihn","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2023.114644_bib44","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0609.1998.tb01710.x","article-title":"Intestinal permeability in patients with acute myeloid leukemia","volume":"61","author":"Sundstr\u00f6m","year":"1998","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.biopha.2023.114644_bib45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3109\/00365511003653581","article-title":"Intestinal permeability, vitamin A absorption and serum alpha-tocopherol during therapy with gefitinib","volume":"70","author":"Melichar","year":"2010","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"10.1016\/j.biopha.2023.114644_bib46","first-page":"3689","article-title":"Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer","volume":"49","author":"Parrilli","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.114644_bib47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1203\/PDR.0b013e3180986d19","article-title":"Chemotherapy does not influence intestinal amino acid uptake in children","volume":"62","author":"de Koning","year":"2007","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.biopha.2023.114644_bib48","first-page":"385","article-title":"Effect of high-dose chemotherapy on intestinal permeability in humans","volume":"92","author":"Keefe","year":"1997"},{"key":"10.1016\/j.biopha.2023.114644_bib49","first-page":"3430","article-title":"Increased gastrointestinal absorption of large molecules in patients after 5-fluorouracil therapy for metastatic colon carcinoma","volume":"40","author":"Siber","year":"1980","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.114644_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-13-56","article-title":"The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study","volume":"13","author":"Russo","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2023.114644_bib51","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/bjc.1987.108","article-title":"Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapy","volume":"55","author":"Selby","year":"1987","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2023.114644_bib52","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/pbc.22210","article-title":"Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients","volume":"53","author":"van Vliet","year":"2009","journal-title":"Pediatr. blood Cancer"},{"key":"10.1016\/j.biopha.2023.114644_bib53","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00280-001-0414-2","article-title":"Alterations in intestinal permeability following the intensified polydrug-chemotherapy IFADIC (ifosfamide, Adriamycin, dacarbazine)","volume":"49","author":"Fazeny-D\u00f6rner","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114644_bib54","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00004836-200103000-00010","article-title":"Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer","volume":"32","author":"Daniele","year":"2001","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.biopha.2023.114644_bib55","doi-asserted-by":"crossref","first-page":"G231","DOI":"10.1152\/ajpgi.00204.2017","article-title":"Animal models of chemotherapy-induced mucositis: translational relevance and challenges","volume":"314","author":"Sangild","year":"2018","journal-title":"Am. J. Physiol. -Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2023.114644_bib56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/SPC.0000000000000421","article-title":"Animal models of mucositis: critical tools for advancing pathobiological understanding and identifying therapeutic targets","volume":"13","author":"Wardill","year":"2019","journal-title":"Curr. Opin. Support. Palliat. care"},{"key":"10.1016\/j.biopha.2023.114644_bib57","first-page":"1376","article-title":"Irinotecan-induced gastrointestinal dysfunction and pain are mediated by common TLR4-dependent mechanisms","volume":"15","author":"Wardill","year":"2016"},{"key":"10.1016\/j.biopha.2023.114644_bib58","first-page":"1","article-title":"Dietary supplementation with omega-3 fatty acid attenuates 5-fluorouracil induced mucositis in mice","volume":"14","author":"de Vasconcelos Generoso","year":"2015","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biopha.2023.114644_bib59","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00280-010-1253-9","article-title":"Zonula Occludens-1 alterations and enhanced intestinal permeability in methotrexate-treated rats","volume":"66","author":"Hamada","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114644_bib60","article-title":"The progression of doxorubicin-induced intestinal mucositis in rats","author":"Kullenberg","year":"2022","journal-title":"Naunyn-Schmiede 'S. Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114644_bib61","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.clnu.2013.09.003","article-title":"Glutamine supplementation, but not combined glutamine and arginine supplementation, improves gut barrier function during chemotherapy-induced intestinal mucositis in rats","volume":"33","author":"Beutheu","year":"2014","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.biopha.2023.114644_bib62","first-page":"433","article-title":"Unanticipated frequency and consequences of regimen-related diarrhea in patients being treated with radiation or chemoradiation regimens for cancers of the head and neck or lung","volume":"23","author":"Sonis","year":"2015","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.biopha.2023.114644_bib63","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00280-016-3150-3","article-title":"Intestinal permeability to iohexol as an in vivo marker of chemotherapy-induced gastrointestinal toxicity in Sprague\u2013Dawley rats","volume":"78","author":"Forsg\u00e5rd","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114644_bib64","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/ijms23031021","article-title":"Chemotherapeutics combined with luminal irritants: effects on small-intestinal mannitol permeability and villus length in rats","volume":"23","author":"Cano-Cebri\u00e1n","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114644_bib65","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1023\/A:1016065715308","article-title":"Comparison between permeability coefficients in rat and human jejunum","volume":"13","author":"Fagerholm","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2023.114644_bib66","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1023\/A:1015927004752","article-title":"Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds","volume":"5","author":"Amidon","year":"1988","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2023.114644_bib67","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1097\/MIB.0000000000000117","article-title":"Mucus layers in inflammatory bowel disease","volume":"20","author":"Johansson","year":"2014","journal-title":"Inflamm. bowel Dis."},{"key":"10.1016\/j.biopha.2023.114644_bib68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/gastro\/goy052","article-title":"Fight them or feed them: how the intestinal mucus layer manages the gut microbiota","volume":"7","author":"Schroeder","year":"2019","journal-title":"Gastroenterol. Rep."},{"key":"10.1016\/j.biopha.2023.114644_bib69","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/SPC.0000000000000423","article-title":"The role of mucins in mucositis","volume":"13","author":"Thorpe","year":"2019","journal-title":"Curr. Opin. Support. Palliat. care"},{"key":"10.1016\/j.biopha.2023.114644_bib70","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nut.2016.05.003","article-title":"Administration of probiotic mixture DM# 1 ameliorated 5-fluorouracil\u2013induced intestinal mucositis and dysbiosis in rats","volume":"33","author":"Tang","year":"2017","journal-title":"Nutrition"},{"key":"10.1016\/j.biopha.2023.114644_bib71","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3920\/BM2017.0082","article-title":"Oral administration of Simbioflora\u00ae(synbiotic) attenuates intestinal damage in a mouse model of 5-fluorouracil-induced mucositis","volume":"9","author":"Trindade","year":"2018","journal-title":"Benef. Microbes"},{"key":"10.1016\/j.biopha.2023.114644_bib72","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jcp.20822","article-title":"Methotrexate\u2010induced mucositis in mucin 2\u2013deficient mice","volume":"210","author":"De Koning","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2023.114644_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4615-4143-1_2","article-title":"Bacterial translocation from the gastrointestinal tract","volume":"2","author":"Berg","year":"1999","journal-title":"Mech. Pathog. Enteric Dis."},{"key":"10.1016\/j.biopha.2023.114644_bib74","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/SPC.0b013e328343a043","article-title":"The significance of altered gastrointestinal permeability in cancer patients","volume":"5","author":"Melichar","year":"2011","journal-title":"Curr. Opin. Support. Palliat. care"},{"key":"10.1016\/j.biopha.2023.114644_bib75","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/apt.13302","article-title":"Chemotherapy\u2010driven dysbiosis in the intestinal microbiome","volume":"42","author":"Montassier","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2023.114644_bib76","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.11882","article-title":"Chemotherapy\u2010induced neutropenia: risks, consequences, and new directions for its management","volume":"100","author":"Crawford","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2023.114644_bib77","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ijc.11196","article-title":"Simultaneous onset of acute inflammatory response, sepsis\u2010like symptoms and intestinal mucosal injury after cancer chemotherapy","volume":"107","author":"Tsuji","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2023.114644_bib78","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/tid.12195","article-title":"Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients","volume":"16","author":"Herbers","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.biopha.2023.114644_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000879","article-title":"The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis","volume":"6","author":"van Vliet","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2023.114644_bib80","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.immuni.2018.07.016","article-title":"A map of toll-like receptor expression in the intestinal epithelium reveals distinct spatial, cell type-specific, and temporal patterns","volume":"49","author":"Price","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2023.114644_bib81","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/19490976.2016.1215806","article-title":"Intestinal bacteria are necessary for doxorubicin-induced intestinal damage but not for doxorubicin-induced apoptosis","volume":"7","author":"Rigby","year":"2016","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biopha.2023.114644_bib82","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/path.3009","article-title":"Severity of doxorubicin\u2010induced small intestinal mucositis is regulated by the TLR\u20102 and TLR\u20109 pathways","volume":"226","author":"Kaczmarek","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.biopha.2023.114644_bib83","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity","volume":"14","author":"Alexander","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2023.114644_bib84","first-page":"301","article-title":"Low-dose methotrexate-induced changes in intestinal permeability determined by polyethylene glycol polymers","volume":"9","author":"Lifschitz","year":"1989","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.biopha.2023.114644_bib85","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1200\/JCO.1997.15.6.2254","article-title":"Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults","volume":"15","author":"Bow","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.114644_bib86","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/clinids\/21.2.361","article-title":"Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen","volume":"21","author":"Bow","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2023.114644_bib87","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0277-5379(91)90214-X","article-title":"Aggressive chemotherapy for acute leukaemia frequently causes intestinal protein leakage","volume":"27","author":"Daenen","year":"1991","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.114644_bib88","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0899-9007(99)00113-6","article-title":"Small bowel permeability in patients with cytostatic therapy","volume":"15","author":"Kohout","year":"1999","journal-title":"Nutrition"},{"key":"10.1016\/j.biopha.2023.114644_bib89","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000067037","article-title":"Assessment of the intestinal permeability following postoperative chemotherapy for human malignant disease","volume":"35","author":"Inutsuka","year":"2003","journal-title":"Eur. Surg. Res."},{"key":"10.1016\/j.biopha.2023.114644_bib90","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/adc.59.5.460","article-title":"Small bowel function in acute lymphoblastic leukaemia","volume":"59","author":"Pearson","year":"1984","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.biopha.2023.114644_bib91","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00442208","article-title":"Intestinal permeability during chemotherapy for childhood tumours","volume":"147","author":"Pledger","year":"1988","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.biopha.2023.114644_bib92","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.bmt.1704863","article-title":"De Pauw, B. Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant","volume":"35","author":"Blijlevens","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.biopha.2023.114644_bib93","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00004836-200308000-00021","article-title":"Intestinal permeability in colorectal cancer patients treated by raltitrexed or irinotecan","volume":"37","author":"Melichar","year":"2003","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.biopha.2023.114644_bib94","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4161\/cbt.5.10.3303","article-title":"A novel non-invasive biomarker for assessment of small intestinal mucositis in children with cancer undergoing chemotherapy","volume":"5","author":"Tooley","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.biopha.2023.114644_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-7-155","article-title":"Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum","volume":"7","author":"Melichar","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2023.114644_bib96","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/030089160609200505","article-title":"Oral glutamine ameliorates chemotherapy-induced changes of intestinal permeability and does not interfere with the antitumor effect of chemotherapy in patients with breast cancer: a prospective randomized trial","volume":"92","author":"Li","year":"2006","journal-title":"Tumori"},{"key":"10.1016\/j.biopha.2023.114644_bib97","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-0773.1999.tb01060.x","article-title":"Changes in intestinal absorption of 5\u2013fluorouracil\u2010treated rats","volume":"85","author":"Hirata","year":"1999","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2023.114644_bib98","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0899-9007(96)00217-1","article-title":"Effects of alanyl-glutamine on gut barrier function","volume":"12","author":"Bai","year":"1996","journal-title":"Nutrition"},{"key":"10.1016\/j.biopha.2023.114644_bib99","first-page":"111","article-title":"Effect of dietary fiber on intestinal barrier function of 5-Fu stressed rats","volume":"199","author":"Deng","year":"1999","journal-title":"Res. Exp. Med. Z. fur die Gesamt Exp. Med. Einschl. Exp. Chir."},{"key":"10.1016\/j.biopha.2023.114644_bib100","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s10620-005-2926-9","article-title":"Early disturbance of microvascular function precedes chemotherapy-induced intestinal injury","volume":"50","author":"Abel","year":"2005","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2023.114644_bib101","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/00365529850171053","article-title":"The influence of apoptosis on intestinal barrier integrity in rats","volume":"33","author":"Sun","year":"1998","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2023.114644_bib102","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1053\/gast.1996.v111.pm8690198","article-title":"The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats","volume":"111","author":"Mao","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2023.114644_bib103","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/B:DDAS.0000011604.45531.2c","article-title":"Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis","volume":"49","author":"Carneiro-Filho","year":"2004","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2023.114644_bib104","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3945\/jn.109.119222","article-title":"A diet containing whey protein, free glutamine, and transforming growth factor-\u03b2 ameliorates nutritional outcome and intestinal mucositis during repeated chemotherapeutic challenges in rats","volume":"140","author":"Boukhettala","year":"2010","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2023.114644_bib105","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/ajcn\/77.5.1296","article-title":"Dietary supplementation with zinc and a growth factor extract derived from bovine cheese whey improves methotrexate-damaged rat intestine","volume":"77","author":"Tran","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2023.114644_bib106","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s10620-008-0275-1","article-title":"Yoghurts containing probiotics reduce disruption of the small intestinal barrier in methotrexate-treated rats","volume":"53","author":"Southcott","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2023.114644_bib107","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s10620-005-9058-0","article-title":"Confirmation and prevention of intestinal barrier dysfunction and bacterial translocation caused by methotrexate","volume":"51","author":"Song","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2023.114644_bib108","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00280-009-1119-1","article-title":"Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats","volume":"65","author":"Maeda","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114644_bib109","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00280-021-04273-7","article-title":"Translational model of melphalan-induced gut toxicity reveals drug-host-microbe interactions that drive tissue injury and fever","volume":"88","author":"Wardill","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114644_bib110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jff.2018.12.027","article-title":"Protective effect of Lactobacillus delbrueckii subsp. Lactis CIDCA 133 in a model of 5 Fluorouracil-Induced intestinal mucositis","volume":"53","author":"De Jesus","year":"2019","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.biopha.2023.114644_bib111","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11745-012-3680-3","article-title":"Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5\u2013fluorouracil administration","volume":"47","author":"Ferreira","year":"2012","journal-title":"Lipids"},{"key":"10.1016\/j.biopha.2023.114644_bib112","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00280-019-03865-8","article-title":"Treatment with selenium-enriched Saccharomyces cerevisiae UFMG A-905 partially ameliorates mucositis induced by 5-fluorouracil in mice","volume":"84","author":"Porto","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114644_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-5751-13-6","article-title":"Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice","volume":"13","author":"Maioli","year":"2014","journal-title":"J. Negat. Results Biomed."},{"key":"10.1016\/j.biopha.2023.114644_bib114","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1017\/S0007114513004248","article-title":"Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice","volume":"111","author":"Justino","year":"2014","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.biopha.2023.114644_bib115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0148607114567508","article-title":"Pretreatment With L\u2010citrulline positively affects the mucosal architecture and permeability of the small intestine in a murine mucositis model","volume":"40","author":"Antunes","year":"2016","journal-title":"J. Parenter. Enter. Nutr."},{"key":"10.1016\/j.biopha.2023.114644_bib116","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/biomedicines9010046","article-title":"Intestinal adaptation upon chemotherapy-induced intestinal injury in mice depends on GLP-2 receptor activation","volume":"9","author":"Billeschou","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2023.114644_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.733555","article-title":"SPAK deficiency attenuates chemotherapy-induced intestinal mucositis","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2023.114644_bib118","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1038\/s41598-020-65792-6","article-title":"Impact of pemetrexed chemotherapy on the gut microbiota and intestinal inflammation of patient-lung-derived tumor xenograft (PDX) mouse models","volume":"10","author":"Pensec","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.114644_bib119","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/pharmaceutics13071021","article-title":"Nanoencapsulated doxorubicin prevents mucositis development in mice","volume":"13","author":"Pinto","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2023.114644_bib120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejphar.2013.06.006","article-title":"The changes induced by cyclophosphamide in intestinal barrier and microflora in mice","volume":"714","author":"Yang","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114644_bib121","first-page":"10","article-title":"A more robust gut microbiota in calorie-restricted mice is associated with attenuated intestinal injury caused by the chemotherapy drug cyclophosphamide","author":"Liu","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.biopha.2023.114644_bib122","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1099\/mic.0.000149","article-title":"Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice","volume":"161","author":"Pedroso","year":"2015","journal-title":"Microbiology"},{"key":"10.1016\/j.biopha.2023.114644_bib123","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1017\/S0007114520004924","article-title":"Effects of dietary fibre intake in chemotherapy-induced mucositis in murine model","volume":"126","author":"Gallotti","year":"2021","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.biopha.2023.114644_bib124","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3181\/0810-RM-301","article-title":"Gastrointestinal microflora and mucins may play a critical role in the development of 5-Fluorouracil-induced gastrointestinal mucositis","volume":"234","author":"Stringer","year":"2009","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.biopha.2023.114644_bib125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/ph13010010","article-title":"Troxerutin prevents 5-fluorouracil induced morphological changes in the intestinal mucosa: role of cyclooxygenase-2 pathway","volume":"13","author":"de Miranda","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2023.114644_bib126","article-title":"\u03b2-patchoulene ameliorates water transport and the mucus barrier in 5-fluorouracil-induced intestinal mucositis rats via the cAMP\/PKA\/CREB signaling pathway","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114644_bib127","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/ijms21020386","article-title":"Fecal microbiota transplantation prevents intestinal injury, upregulation of toll-like receptors, and 5-fluorouracil\/oxaliplatin-induced toxicity in colorectal cancer","volume":"21","author":"Chang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114644_bib128","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s10620-006-9174-5","article-title":"Alterations in epithelial and mesenchymal intestinal gene expression during doxorubicin-induced mucositis in mice","volume":"52","author":"de Koning","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2023.114644_bib129","doi-asserted-by":"crossref","first-page":"G1037","DOI":"10.1152\/ajpgi.2000.279.5.G1037","article-title":"Selective sparing of goblet cells and paneth cells in the intestine of methotrexate-treated rats","volume":"279","author":"Verburg","year":"2000","journal-title":"Am. J. Physiol. -Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2023.114644_bib130","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1177\/002215540205001113","article-title":"Specific responses in rat small intestinal epithelial mRNA expression and protein levels during chemotherapeutic damage and regeneration","volume":"50","author":"Verburg","year":"2002","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.biopha.2023.114644_bib131","doi-asserted-by":"crossref","first-page":"G785","DOI":"10.1152\/ajpgi.1999.277.4.G785","article-title":"Temporal changes in TFF3 expression and jejunal morphology during methotrexate-induced damage and repair","volume":"277","author":"Xian","year":"1999","journal-title":"Am. J. Physiol. -Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2023.114644_bib132","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/mi.2013.124","article-title":"IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice","volume":"7","author":"Guabiraba","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biopha.2023.114644_bib133","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00280-008-0855-y","article-title":"Irinotecan-induced mucositis is associated with changes in intestinal mucins","volume":"64","author":"Stringer","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114644_bib134","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2613.2009.00671.x","article-title":"Irinotecan\u2010induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile","volume":"90","author":"Stringer","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.biopha.2023.114644_bib135","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s12253-019-00644-x","article-title":"Irinotecan-induced mucositis is associated with goblet cell dysregulation and neural cell damage in a tumour bearing DA rat model","volume":"26","author":"Thorpe","year":"2020","journal-title":"Pathol. Oncol. Res.: POR"},{"key":"10.1016\/j.biopha.2023.114644_bib136","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1034\/j.1399-302X.2003.00075.x","article-title":"Oral and intestinal microflora in 5\u2013fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria","volume":"18","author":"Von B\u00fcltzingsl\u00f6wen","year":"2003","journal-title":"Oral. Microbiol. Immunol."},{"key":"10.1016\/j.biopha.2023.114644_bib137","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1139\/m91-037","article-title":"Induction of lethal infection with indigenous Escherichia coli in mice by fluorouracil","volume":"37","author":"Nomoto","year":"1991","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.biopha.2023.114644_bib138","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jss.2005.04.037","article-title":"The effect of granulocyte macrophage-colony stimulating factor on bacterial translocation after administration of 5-fluorouracil in rats","volume":"128","author":"Kucuk","year":"2005","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.biopha.2023.114644_bib139","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01577729","article-title":"Bacterial translocation from the gastrointestinal tracts of mice receiving immunosuppressive chemotherapeutic agents","volume":"8","author":"Berg","year":"1983","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.biopha.2023.114644_bib140","article-title":"Amelioration of chemotherapy-induced intestinal mucositis by orally administered probiotics in a mouse model","volume":"10","author":"Yeung","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2023.114644_bib141","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.3748\/wjg.v13.i18.2596","article-title":"Effects of granulocyte-colony stimulating factor on peritoneal defense mechanisms and bacterial translocation after administration of systemic chemotherapy in rats","volume":"13","author":"Cerci","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2023.114644_bib142","doi-asserted-by":"crossref","first-page":"3068393","DOI":"10.1155\/2021\/3068393","article-title":"Immune modulation effects of lactobacillus casei variety rhamnosus on enterocytes and intestinal stem cells in a 5-FU-induced mucositis mouse model","volume":"2021","author":"Yeung","year":"2021","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.biopha.2023.114644_bib143","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1093\/jn\/126.10.2519","article-title":"Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats","volume":"126","author":"Howarth","year":"1996","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2023.114644_bib144","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00284-005-0177-9","article-title":"Green fluorescent protein labeling escherichia coli TG1 confirms intestinal bacterial translocation in a rat model of chemotherapy","volume":"52","author":"Song","year":"2006","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.biopha.2023.114644_bib145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jss.2010.10.003","article-title":"Irinotecan injures tight junction and causes bacterial translocation in rat","volume":"173","author":"Nakao","year":"2012","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.biopha.2023.114644_bib146","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1111\/bph.15609","article-title":"TLR4 deficiency upregulates TLR9 expression and enhances irinotecan-related intestinal mucositis and late-onset diarrhoea","volume":"178","author":"Wong","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114644_bib147","article-title":"The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats","volume":"9","author":"Lin","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2023.114644_bib148","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.immuni.2016.09.009","article-title":"Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects","volume":"45","author":"Daill\u00e8re","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2023.114644_bib149","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3945\/jn.110.136986","article-title":"Bacterial translocation is reduced by a specific nutritional combination in mice with chemotherapy-induced neutropenia","volume":"141","author":"Faber","year":"2011","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2023.114644_bib150","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1128\/IAI.00684-15","article-title":"Murine model of chemotherapy-induced extraintestinal pathogenic Escherichia coli translocation","volume":"83","author":"Green","year":"2015","journal-title":"Infect. Immun."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223004328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223004328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:18:32Z","timestamp":1778246312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223004328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":150,"alternative-id":["S0753332223004328"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114644","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review on the effect of chemotherapy on the intestinal barrier: Epithelial permeability, mucus and bacterial translocation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114644"}}